Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 2Active not recruiting 2Withdrawn 1Terminated 1Suspended 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Specimen Handling 334Magnetic Resonance Spectroscopy 334Radiotherapy 316Cyclophosphamide 296pembrolizumab 281Cisplatin 269Carboplatin 246Drug Therapy 238Blood Specimen Collection 233Biopsy 204Bevacizumab 185Gemcitabine 181venetoclax 172Radiosurgery 172Oxaliplatin 164Capecitabine 164fludarabine 161Paclitaxel 158Nivolumab 158Standard of Care 136Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 126Fluorouracil 124Docetaxel 113Rituximab 112tislelizumab 110Cytarabine 104Azacitidine 101Radiation 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × OTHER × sotigalimab × Clear all
NCT02600949 2026-04-24

Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer

M.D. Anderson Cancer Center

Phase 1 Recruiting
300 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡